Posted by Michael Wonder on 13 Nov 2023
Informing real-time decisions with post-market drug evidence
10 November 2023 - It’s been one year since CADTH launched the Post-Market Drug Evaluation (PMDE) Program to provide decision-makers with evidence about drugs that have been approved and are already in use by people in Canada.
With the PMDE program, CADTH is enhancing how we evaluate drugs across their life cycle and advancing efforts to incorporate real-world evidence into our assessments.
